Understand the molecule.
Question the promise.
Plain-English explainers that distinguish clinical findings, early research and unanswered questions.
32 articles · Evidence reviewed 10 Sep 2026 · Educational articles · Not clinically peer-reviewed.
Semaglutide ↗
A GLP-1 medicine with substantial human evidence. Product and indication matter.
Read the evidence →Tirzepatide ↗
One molecule, two receptor targets: GIP and GLP-1.
Read the evidence →Retatrutide ↗
A triple-receptor agonist with promising trial results and unresolved clinical questions.
Read the evidence →Liraglutide ↗
A GLP-1 analogue used in approved prescription medicines.
Read the evidence →BPC-157 ↗
A repair-research peptide whose popularity exceeds the strength of its clinical evidence.
Read the evidence →TB-500 / thymosin beta-4 ↗
Names that are often used interchangeably can refer to different materials.
Read the evidence →GHK-Cu ↗
A copper-binding tripeptide studied in skin and tissue biology.
Read the evidence →CJC-1295 ↗
A growth-hormone-releasing hormone analogue with important naming differences.
Read the evidence →Ipamorelin ↗
A growth-hormone secretagogue studied through the ghrelin receptor pathway.
Read the evidence →Tesamorelin ↗
Human evidence concerns specific medical populations, not general fat-loss promises.
Read the evidence →MOTS-c ↗
A mitochondrial-derived peptide at the intersection of metabolism and exercise.
Read the evidence →Thymosin alpha-1 ↗
An immune-modulating peptide whose evidence depends on the disease being studied.
Read the evidence →PT-141 / bremelanotide ↗
A melanocortin receptor agonist studied for a defined sexual-health indication.
Read the evidence →Epitalon ↗
Telomere-related claims should not be mistaken for demonstrated life extension.
Read the evidence →KPV ↗
A three-amino-acid fragment studied in inflammation models.
Read the evidence →AOD-9604 ↗
A modified growth-hormone fragment marketed well beyond what is established.
Read the evidence →99% pure. But pure of what? ↗
The number on the label is only one part of the evidence.
Read the evidence →How to read a peptide COA ↗
Follow the sample, the method and the evidence back to their source.
Read the evidence →Endotoxins ≠ sterility ↗
A product can pass one test and fail the other.
Read the evidence →What better purification should prove ↗
Reward measured outcomes, not an expensive-sounding manufacturing story.
Read the evidence →Research peptide or approved medicine? ↗
The molecule’s name does not establish the product’s medical status.
Read the evidence →From a promising molecule to a proven benefit ↗
Mechanisms, biomarkers and patient outcomes answer different questions.
Read the evidence →BPC-157 and Recovery Claims: What the Evidence Can Actually Tell You ↗
BPC-157 attracts strong interest in injury recovery. The central question is how far experimental findings support the claims made about people.
Read the evidence →Endotoxins, Sterility and Peptide Testing: A Clear Guide to the Differences ↗
A chemical purity report does not answer every contamination question. This guide explains how to read microbial and endotoxin evidence without overstating it.
Read the evidence →How to Compare Peptide Suppliers Without Falling for Marketing ↗
A useful supplier review follows the evidence from the business identity to the actual sample. This guide explains how to build that comparison step by step.
Read the evidence →How to Read a Peptide COA: A Practical Evidence Guide ↗
A certificate of analysis can answer useful questions—if you know exactly what was tested, how it was measured and which sample the result belongs to.
Read the evidence →How to Read Peptide Studies: From Cell Experiments to Clinical Evidence ↗
A study link is the beginning of an assessment. Learn how to decide whether the experiment actually supports the health claim attached to it.
Read the evidence →Longevity Peptides: How to Judge Biomarkers, Mechanisms and Human Evidence ↗
Longevity claims often begin with an interesting cellular result. The challenge is determining whether that result supports a meaningful benefit in people.
Read the evidence →Peptide Manufacturing and Purification: What Quality Claims Really Mean ↗
Understanding the steps between a chemical sequence and a finished research product helps you ask better questions about purity, residues and manufacturing claims.
Read the evidence →Peptide Purity vs Safety: Why 99% Is Only One Part of the Story ↗
Purity, identity, quantity and contamination testing answer different questions. Understanding those differences makes supplier comparisons much more useful.
Read the evidence →Peptide Reviews and User Experiences: How to Separate Useful Reports from Hype ↗
Customer stories can reveal service problems and unanswered questions. They become misleading when opinions are treated as laboratory findings or clinical proof.
Read the evidence →Semaglutide, Tirzepatide and Retatrutide: How to Compare the Evidence ↗
Three widely discussed metabolic peptides have different mechanisms, development histories and evidence. A useful comparison goes beyond the largest weight-loss headline.
Read the evidence →No articles match. Try another search or topic.